SignalCorporate
MODERNA SHARES CLIMB OVER 150% AS MRNA VACCINE WITH MERCK SUCCEEDS IN LARGE TRIAL FOR SKIN CANCER - MINT
MRNA vaccine with Merck succeeds in large skin cancer trial, driving shares up over 110%.
What changed
MRNA vaccine with Merck succeeds in large skin cancer trial, driving shares up over 110%.
Why it matters
MRNA vaccine with Merck succeeds in large skin cancer trial, driving shares up over 110%. — impact context not separately stored; see What changed.